Drug intelligence / Profile preview

Hyaluronidase + lactated Ringer's solution

Development stage
Unknown
Lead developer
Halozyme
Modality
Therapeutic Enzymes → Recombinant Proteins and Enzymes
Administration
Subcutaneous
01

Overview

Hyaluronidase + lactated Ringer’s solution is a combination therapy used primarily to facilitate subcutaneous fluid administration (hypodermoclysis) for hydration. Hyaluronidase is an enzyme that temporarily depolymerizes hyaluronic acid in the interstitial space, increasing tissue permeability and allowing for more rapid dispersion and absorption of injected fluids or drugs. When combined with isotonic solutions such as lactated Ringer’s, it enables faster and larger volume subcutaneous infusions compared to fluid alone. Lactated Ringer’s is a sterile electrolyte replacement fluid containing sodium chloride, sodium lactate, potassium chloride, calcium chloride, and water; it serves as a source of water and electrolytes or as an alkalinizing agent. This combination is indicated for rehydration in adults and children when intravenous access is difficult or not preferred[3][5][6]. The mechanism involves enzymatic breakdown of extracellular matrix components by hyaluronidase (targeting hyaluronic acid), facilitating the absorption of the infused isotonic electrolyte solution.

Other names
recombinant human hyaluronidase + lactated ringer's solutionrHuPH20 + LR solution

Beyond the preview

Go deeper on Hyaluronidase + lactated Ringer's solution.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hyaluronidase + lactated Ringer's solution.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call